Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers.
Tré-Hardy M, Cupaiolo R, Papleux E, Wilmet A, Horeanga A, Antoine-Moussiaux T, Della Vecchia A, Beukinga I, Vekemans M, Blairon L. Tré-Hardy M, et al. Among authors: papleux e. J Infect. 2021 Aug;83(2):237-279. doi: 10.1016/j.jinf.2021.03.025. Epub 2021 Apr 1. J Infect. 2021. PMID: 33811939 Free PMC article. No abstract available.
Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected.
Tré-Hardy M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, Coman-Vlagea N, Della Vecchia A, Horeanga A, Papleux E, Vekemans M, Beukinga I, Blairon L. Tré-Hardy M, et al. Among authors: papleux e. J Infect. 2022 Apr;84(4):e31-e33. doi: 10.1016/j.jinf.2022.02.009. Epub 2022 Feb 16. J Infect. 2022. PMID: 35181372 Free PMC article. No abstract available.
Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO).
Gyselinck I, Liesenborghs L, Belmans A, Engelen MM, Betrains A, Van Thillo Q, Nguyen PAH, Goeminne P, Soenen AC, De Maeyer N, Pilette C, Papleux E, Vanderhelst E, Derweduwen A, Alexander P, Bouckaert B, Martinot JB, Decoster L, Vandeurzen K, Schildermans R, Verhamme P, Janssens W, Vos R. Gyselinck I, et al. Among authors: papleux e. ERJ Open Res. 2022 Feb 28;8(1):00610-2021. doi: 10.1183/23120541.00610-2021. eCollection 2022 Jan. ERJ Open Res. 2022. PMID: 35233389 Free PMC article.